Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glycosylation defining cancer malignancy: new wine in an old bottle.

× No keyword cloud information.

34 in total

1. Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppresion] of activation.

Authors: X Q Wang; P Sun; M O'Gorman; T Tai; A S Paller
Journal: Glycobiology Date: 2001-07 Impact factor: 4.313

2. Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1.

Authors: R Kang; H Saito; Y Ihara; E Miyoshi; N Koyama; Y Sheng; N Taniguchi
Journal: J Biol Chem Date: 1996-10-25 Impact factor: 5.157

3. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.

Authors: M Adachi; T Taki; Y Ieki; C L Huang; M Higashiyama; M Miyake
Journal: Cancer Res Date: 1996-04-15 Impact factor: 12.701

Review 4. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.

Authors: S Hakomori
Journal: Cancer Res Date: 1996-12-01 Impact factor: 12.701

5. GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy.

Authors: M Ono; K Handa; S Sonnino; D A Withers; H Nagai; S Hakomori
Journal: Biochemistry Date: 2001-05-29 Impact factor: 3.162

6. Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation.

Authors: M Ono; K Handa; D A Withers; S Hakomori
Journal: Cancer Res Date: 1999-05-15 Impact factor: 12.701

7. Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching.

Authors: Shinji Ihara; Eiji Miyoshi; Jeong Heon Ko; Kohei Murata; Susumu Nakahara; Koichi Honke; Robert B Dickson; Chen-Yong Lin; Naoyuki Taniguchi
Journal: J Biol Chem Date: 2002-02-25 Impact factor: 5.157

8. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins.

Authors: E C Brinkman-Van der Linden; A Varki
Journal: J Biol Chem Date: 2000-03-24 Impact factor: 5.157

9. Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study.

Authors: S Nakamori; M Kameyama; S Imaoka; H Furukawa; O Ishikawa; Y Sasaki; T Kabuto; T Iwanaga; Y Matsushita; T Irimura
Journal: Cancer Res Date: 1993-08-01 Impact factor: 12.701

10. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis.

Authors: M Ono; M Sakamoto; Y Ino; Y Moriya; K Sugihara; T Muto; S Hirohashi
Journal: Cancer Date: 1996-09-15 Impact factor: 6.860

326 in total

1. Transcriptional regulation of the protocadherin β cluster during Her-2 protein-induced mammary tumorigenesis results from altered N-glycan branching.

Authors: Huabei Guo; Alison Nairn; Mitche dela Rosa; Tamas Nagy; Shaying Zhao; Kelley Moremen; Michael Pierce
Journal: J Biol Chem Date: 2012-06-04 Impact factor: 5.157

2. Altered expression of sialylated glycoproteins in breast cancer using hydrazide chemistry and mass spectrometry.

Authors: Yuan Tian; Francisco J Esteva; Jin Song; Hui Zhang
Journal: Mol Cell Proteomics Date: 2012-02-07 Impact factor: 5.911

3. Plasma membrane-associated glycohydrolases activation by extracellular acidification due to proton exchangers.

Authors: Massimo Aureli; Nicoletta Loberto; Rosaria Bassi; Anita Ferraretto; Silvia Perego; Patrizia Lanteri; Vanna Chigorno; Sandro Sonnino; Alessandro Prinetti
Journal: Neurochem Res Date: 2012-02-23 Impact factor: 3.996

Review 4. Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors: Alfred H Merrill
Journal: Chem Rev Date: 2011-09-26 Impact factor: 60.622

5. Specific posttranslational modification regulates early events in mammary carcinoma formation.

Authors: Hua-Bei Guo; Heather Johnson; Matthew Randolph; Tamas Nagy; Ryan Blalock; Michael Pierce
Journal: Proc Natl Acad Sci U S A Date: 2010-11-15 Impact factor: 11.205

6. Simultaneous quantification of N- and O-glycans using a solid-phase method.

Authors: Shuang Yang; Yingwei Hu; Lori Sokoll; Hui Zhang
Journal: Nat Protoc Date: 2017-05-18 Impact factor: 13.491

Review 7. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains.

Authors: Adriane Regina Todeschini; Sen-itiroh Hakomori
Journal: Biochim Biophys Acta Date: 2007-10-22

8. Increased expression of MUC1 and sialyl Lewis antigens in different areas of clear renal cell carcinoma.

Authors: Małgorzata Borzym-Kluczyk; Iwona Radziejewska; Marzanna Cechowska-Pasko
Journal: Clin Exp Nephrol Date: 2014-08-05 Impact factor: 2.801

Review 9. Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI.

Authors: Pradman K Qasba; Boopathy Ramakrishnan; Elizabeth Boeggeman
Journal: AAPS J Date: 2006-03-24 Impact factor: 4.009

10. Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.

Authors: Yi-Wei Lou; Pao-Yuan Wang; Shih-Chi Yeh; Po-Kai Chuang; Shiou-Ting Li; Chung-Yi Wu; Kay-Hooi Khoo; Michael Hsiao; Tsui-Ling Hsu; Chi-Huey Wong
Journal: Proc Natl Acad Sci U S A Date: 2014-02-03 Impact factor: 11.205